Literature DB >> 4098060

5-hydroxytryptophan in parkinsonism.

T N Chase.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4098060     DOI: 10.1016/s0140-6736(70)92837-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Quantitative study of the effect of L-dopa and phenoxybenzamine on the rigidity of Parkinson's disease.

Authors:  C J Andrews; D Burke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

3.  Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

4.  5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

Authors:  B Johansson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

Review 5.  Current concepts of Parkinsonism.

Authors:  J Pearce; I Pearce
Journal:  Postgrad Med J       Date:  1971-12       Impact factor: 2.401

6.  CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Authors:  D L Davidson; C M Yates; C Mawdsley; I A Pullar; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

7.  Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.

Authors:  E Beretta; F Regli; G de Crousaz; A J Steck
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

8.  Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.

Authors:  K Ikeguchi; A Kuroda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

9.  5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administration.

Authors:  P Angwin; P Berger; V Zarcone; H K Brodie; J Barchas
Journal:  Neurochem Res       Date:  1976-12       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.